Liernu, Belgium

Vincent Lannoy



 

Average Co-Inventor Count = 6.8

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Gosselies, BE (2008)
  • Liernu, BE (2005 - 2019)

Company Filing History:


Years Active: 2005-2019

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Vincent Lannoy: Innovator in Organic Compounds

Introduction

Vincent Lannoy is a notable inventor based in Liernu, Belgium. He has made significant contributions to the field of organic compounds, holding a total of four patents. His work focuses on the interaction between G-protein coupled receptors and their modulators, which has important implications for medical treatments.

Latest Patents

Lannoy's latest patents include innovative methods related to modulators of the interaction between G-protein coupled receptor 15 (GPR15) and c10orf99. This invention describes modulators that may be small chemical molecules, antibodies, or other therapeutic proteins. Additionally, he has developed a method for detecting the dysregulation of GPR86 activity, which is crucial for understanding various medical conditions.

Career Highlights

Throughout his career, Vincent Lannoy has worked with prominent companies such as Euroscreen S.A. and Novartis AG. His experience in these organizations has allowed him to advance his research and contribute to the development of new therapeutic approaches.

Collaborations

Lannoy has collaborated with notable colleagues, including Michel Detheux and Marc Parmentier. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Vincent Lannoy is a distinguished inventor whose work in organic compounds has the potential to influence medical treatments significantly. His patents and collaborations reflect his commitment to advancing scientific knowledge and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…